This task order establishes services for H5 pandemic readiness for acquisition of medical countermeasures (mcms) for pandemic influenza and emerging diseases preparedness and response under contract…
Active Awarded Last action
- Contract number
- 75A50124F61014
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $18,193,095
Award facts
- Contract value 19% obligated
-
- $18,193,095.10 Current, with exercised options
- $94,368,875.10 Potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$218,813 | |
| Exercise an Option | $9,439,980 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $8,753,115 | |
| Original award | $218,813 |
About this award
The Office of the Assistant Secretary for Preparedness and Response (HHS) issued a $94.4 million delivery order to Glaxosmithkline, LLC on May 10, 2024, for medical countermeasures supporting H5 pandemic readiness, influenza preparedness, and emerging disease response under parent contract 75A50122D00002.
Place of performance is Durham, NC. The order carries a firm fixed price structure with an ultimate completion date of February 21, 2027. No set-aside applies to this award.
Description
This task order establishes services for H5 pandemic readiness for acquisition of medical countermeasures (mcms) for pandemic influenza and emerging diseases preparedness and response under contract 75A50122D00002.
Quick answers
Who was awarded contract 75A50124F61014?
75A50124F61014 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 10, 2024.
How much is contract 75A50124F61014 worth?
The government has obligated $18,193,095 on 75A50124F61014. Its potential value, with all options, is $94,368,875.
Is contract 75A50124F61014 an order under another contract?
Yes. 75A50124F61014 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61014 competed?
The extent of competition for 75A50124F61014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award